Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 303 clinical trials
Village-Integrated Eye Worker Trial II

treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these

fundus photography
diabetic retinopathy
intraocular pressure
cataract
optical coherence tomography
  • 8 views
  • 28 Mar, 2021
  • 2 locations
Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

The study is a 64-week randomized, double-masked, multi-center, active-controlled, two-arm study in patients with nAMD (neovascular age related macular degeneration) who have not previously

vegf
edema
diabetic retinopathy
retinal angiomatous proliferation
retinal pigment
  • 30 views
  • 20 Jun, 2021
  • 135 locations
A Study to Evaluate the Efficacy Durability and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

This Phase 3 study will evaluate the efficacy, durability, and safety of KSI-301 compared to aflibercept, in participants with macular edema due to treatment-nave branch (BRVO) or central retinal vein occlusion (CRVO).

aflibercept
macular edema
edema
spectral domain optical coherence tomography
retinal vein occlusion
  • 122 views
  • 21 Feb, 2021
  • 86 locations
Lowering Events in Non-proliferative Retinopathy in Scotland

LENS is a streamlined multicentre randomized placebo-controlled parallel-group trial investigating the effect of fenofibrate treatment on the progression of diabetic retinopathy/maculopathy

diabetic retinopathy
retinopathy
retinal screening
macular degeneration
diabetes
  • 298 views
  • 26 Jan, 2021
  • 16 locations
Village-Integrated Eye Worker Trial II - Pilot

treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these

fundus photography
diabetic retinopathy
cataract
visual impairment
blindness
  • 122 views
  • 25 Mar, 2021
  • 1 location
Cohort Study of the Clinical Course of Macular Diseases in Kagawa

, including age-related macular degeneration (AMD), polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation (RAP), central serous chorioretinopathy (CSC), myopic choroidal

  • 0 views
  • 22 Jan, 2021
  • 1 location
Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comt

diseases), neuro-vascular diseases (Cerebrovascular Accident (CVA)), Age-related Macular Degeneration(AMD) and heart disease (heart failure), aged 60 years old and living in Burgundy or Franche-Comte. By

metastasis
degenerative disease
atrophy
heart disease
mini-mental state examination
  • 0 views
  • 21 Jan, 2021
  • 5 locations
Bimodal and Coaxial High Resolution Ophtalmic Imaging

The knowledge of the pathogenesis of retinal affections, a major cause of blindness, has greatly benefited from recent advances in retinal imaging. However, optical aberrations of the ocular media limit the resolution that can be achieved by current techniques. The use of an adaptive optics system improves the resolution of …

  • 0 views
  • 26 Jan, 2021
  • 1 location
Multimodal Ophthalmic Imaging

Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye. The use of a high-resolution imaging system improves the resolution of …

  • 0 views
  • 23 Jan, 2021
  • 1 location
This Study Tests the Safety of Inhaled BAY1237592 How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

In this trial the effects of the inhaled drug BAY1237592 will be studied in patients with high blood pressure affecting the blood vessels in the lungs due to Pulmonary Arterial Hypertension (PAH) and due to Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Pulmonary hypertension is characterized by the elevation of pressure in …

nitric oxide
endothelin receptor antagonist
iloprost
endothelin
pulmonary arterial hypertension
  • 69 views
  • 14 Jun, 2021
  • 58 locations